Position in ERAS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$14,956,872
+$10,667,379 QoQ
Shares Held
924,405
-19.8% QoQ
Ownership
0.297%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 80.65209513146294.ToString("F0")%
Shared 0.ToString("F0")%
None 19.347904868537057.ToString("F0")%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,578,690,346 across 405 Biotechnology names. ERAS ranks #64 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in ERAS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,956,872 | 924,405 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $4,289,493 | 1,153,090 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,766,509 | 1,269,042 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $1,743,161 | 1,372,569 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,938,883 | 1,415,244 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,701,206 | 1,474,585 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $5,526,921 | 2,024,514 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $4,808,768 | 2,037,614 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $136,276 | 66,154 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $184,957 | 86,835 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $161,753 | 82,109 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $186,318 | 67,507 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $167,759 | 55,734 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $615,855 | 142,890 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $341,997 | 43,846 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $224,592 | 40,322 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $431,839 | 50,214 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $370,226 | 23,763 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $161,611 | 7,616 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||